Wang Y, Zhou L-B, Li X-H
Department of General Surgery, Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Department of Digestive Medicine, Shanghai Eighth People's Hospital, Shanghai, China
Genet Mol Res. 2014 Dec 12;13(4):10398-403. doi: 10.4238/2014.December.12.1.
The prognostic role of S100A4 in gastric cancer is still under debate. The present meta-analysis aimed to evaluate the relationship between S10A4 levels and the prognosis of gastric cancer. We performed a meta-analysis of published studies assessing the relationship between S100A4 and gastric cancer prognosis. We used the Revman 5.0 software to perform literature retrieval, article selection, data collection, and statistical analysis. A fixed-effect model was used to pool the hazard ratio (HR) and 95% confidence intervals (95%CI). A total of 7 eligible studies that included 1257 gastric cancer patients were analyzed. We did not find a prognostic value for S100A4 in gastric cancer (HR = 1.48, 95%CI = 0.77 to 2.82, P = 0.24). In conclusion, the present study indicated that S100A4 expression level is not a prognostic factor for gastric cancer.
S100A4在胃癌中的预后作用仍存在争议。本荟萃分析旨在评估S10A4水平与胃癌预后之间的关系。我们对已发表的评估S100A4与胃癌预后关系的研究进行了荟萃分析。我们使用Revman 5.0软件进行文献检索、文章筛选、数据收集和统计分析。采用固定效应模型汇总风险比(HR)和95%置信区间(95%CI)。共分析了7项符合条件的研究,纳入1257例胃癌患者。我们未发现S100A4在胃癌中有预后价值(HR = 1.48,95%CI = 0.77至2.82,P = 0.24)。总之,本研究表明S100A4表达水平不是胃癌的预后因素。